Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India
AK Singh, R Singh, SR Joshi, A Misra - Diabetes & Metabolic Syndrome …, 2021 - Elsevier
Background and aims There are increasing case reports of rhino-orbital mucormycosis in
people with coronavirus disease 2019 (COVID-19), especially from India. Diabetes mellitus …
people with coronavirus disease 2019 (COVID-19), especially from India. Diabetes mellitus …
The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries
M Hoenigl, D Seidel, A Carvalho… - The Lancet …, 2022 - thelancet.com
Reports of COVID-19-associated mucormycosis have been increasing in frequency since
early 2021, particularly among patients with uncontrolled diabetes. Patients with diabetes …
early 2021, particularly among patients with uncontrolled diabetes. Patients with diabetes …
[HTML][HTML] Multicenter epidemiologic study of coronavirus disease–associated mucormycosis, India
Abstract During September–December 2020, we conducted a multicenter retrospective
study across India to evaluate epidemiology and outcomes among cases of coronavirus …
study across India to evaluate epidemiology and outcomes among cases of coronavirus …
Coronavirus disease (Covid-19) associated mucormycosis (CAM): case report and systematic review of literature
Abstract Severe coronavirus disease (COVID-19) is currently managed with systemic
glucocorticoids. Opportunistic fungal infections are of concern in such patients. While COVID …
glucocorticoids. Opportunistic fungal infections are of concern in such patients. While COVID …
Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India–Collaborative OPAI …
M Sen, SG Honavar, R Bansal… - Indian journal of …, 2021 - journals.lww.com
Purpose: COVID-19-associated rhino-orbital-cerebral mucormycosis (ROCM) has reached
epidemic proportion during India's second wave of COVID-19 pandemic, with several risk …
epidemic proportion during India's second wave of COVID-19 pandemic, with several risk …
Epidemiology and diagnosis of mucormycosis: an update
A Skiada, I Pavleas, M Drogari-Apiranthitou - Journal of fungi, 2020 - mdpi.com
Mucormycosis is an angioinvasive fungal infection, due to fungi of the order Mucorales. Its
incidence cannot be measured exactly, since there are few population-based studies, but …
incidence cannot be measured exactly, since there are few population-based studies, but …
Epidemiology of mucormycosis in India
H Prakash, A Chakrabarti - Microorganisms, 2021 - mdpi.com
Mucormycosis is an angioinvasive disease caused by saprophytic fungi of the order
Mucorales. The exact incidence of mucormycosis in India is unknown due to the lack of …
Mucorales. The exact incidence of mucormycosis in India is unknown due to the lack of …
Epidemiology and pathophysiology of COVID-19-associated mucormycosis: India versus the rest of the world
Abstract The coronavirus disease 2019 (COVID-19) pandemic has led to a concerning
resurgence of mucormycosis. More than 47,000 cases of mucormycosis were reported in …
resurgence of mucormycosis. More than 47,000 cases of mucormycosis were reported in …
Mucormycosis: An opportunistic pathogen during COVID-19
I Mahalaxmi, K Jayaramayya, D Venkatesan… - Environmental …, 2021 - Elsevier
The pandemic of coronavirus disease 2019 (COVID-19) still remains on an upsurge trend.
The second wave of this disease has led to panic in many countries, including India and …
The second wave of this disease has led to panic in many countries, including India and …
ECMM/ISHAM recommendations for clinical management of COVID‐19 associated mucormycosis in low‐and middle‐income countries
Reports are increasing on the emergence of COVID‐19–associated mucormycosis (CAM)
globally, driven particularly by low‐and middle‐income countries. The recent unprecedented …
globally, driven particularly by low‐and middle‐income countries. The recent unprecedented …